Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.
Saved in:
| Title: | Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial. |
|---|---|
| Authors: | Mai EK; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Bertsch U; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Pozek E; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Besemer B; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Hanoun C; Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany., Schroers R; Medical Clinic II-Hematology and Oncology, Ruhr-University Bochum, Bochum, Germany., von Metzler I; Department of Medicine II-Hematology and Oncology, Goethe-University Frankfurt, University Hospital, Frankfurt am Main, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Mann C; Department for Hematology, Oncology and Immunology, University Hospital Gießen and Marburg, Marburg, Germany., Leypoldt LB; Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Heilmeier B; Clinic for Oncology and Hematology, Hospital Barmherzige Brueder Regensburg, Regensburg, Germany., Huhn S; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Vogel SK; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Hundemer M; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany., Luntz S; Coordination Centre for Clinical Trials (KKS) Heidelberg, Heidelberg, Germany., Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Tichy D; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Holderried TAW; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany., Trautmann-Grill K; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Germany., Gezer D; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany., Klaiber-Hakimi M; Clinic for Hematology, Oncology and Palliative Care, Marien Hospital Düsseldorf, Düsseldorf, Germany., Müller M; Clinic for Hematology, Oncology and Immunology, Klinikum Siloah Hannover, Hannover, Germany., Shumilov E; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Knauf W; Center for Hematology and Oncology Bethanien, Frankfurt am Main, Germany., Michel CS; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany., Geer T; Department of Internal Medicine III, Diakoneo Clinic Schwäbisch-Hall, Schwäbisch-Hall, Germany., Riesenberg H; Hematology/Oncology Center, Bielefeld, Germany., Lutz C; Hematology/Oncology Center, Koblenz, Germany., Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Hoffmann M; Medical Clinic A, Clinic Ludwigshafen, Ludwigshafen, Germany., Weisel KC; Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Salwender HJ; Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany. |
| Corporate Authors: | German-Speaking Myeloma Multicenter Group (GMMG) HD7 Investigators, German-speaking Myeloma Multicenter Group (GMMG) HD7 |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Apr 10; Vol. 43 (11), pp. 1279-1288. Date of Electronic Publication: 2024 Dec 09. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39652594 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mai+EK%22">Mai EK</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bertsch+U%22">Bertsch U</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Pozek+E%22">Pozek E</searchLink>; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Fenk+R%22">Fenk R</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Besemer+B%22">Besemer B</searchLink>; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hanoun+C%22">Hanoun C</searchLink>; Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Schroers+R%22">Schroers R</searchLink>; Medical Clinic II-Hematology and Oncology, Ruhr-University Bochum, Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22von+Metzler+I%22">von Metzler I</searchLink>; Department of Medicine II-Hematology and Oncology, Goethe-University Frankfurt, University Hospital, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Hänel+M%22">Hänel M</searchLink>; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.<br /><searchLink fieldCode="AU" term="%22Mann+C%22">Mann C</searchLink>; Department for Hematology, Oncology and Immunology, University Hospital Gießen and Marburg, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Leypoldt+LB%22">Leypoldt LB</searchLink>; Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Heilmeier+B%22">Heilmeier B</searchLink>; Clinic for Oncology and Hematology, Hospital Barmherzige Brueder Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Huhn+S%22">Huhn S</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Vogel+SK%22">Vogel SK</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hundemer+M%22">Hundemer M</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Scheid+C%22">Scheid C</searchLink>; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Blau+IW%22">Blau IW</searchLink>; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Luntz+S%22">Luntz S</searchLink>; Coordination Centre for Clinical Trials (KKS) Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weinhold+N%22">Weinhold N</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Tichy+D%22">Tichy D</searchLink>; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Holderried+TAW%22">Holderried TAW</searchLink>; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Trautmann-Grill+K%22">Trautmann-Grill K</searchLink>; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Gezer+D%22">Gezer D</searchLink>; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.<br /><searchLink fieldCode="AU" term="%22Klaiber-Hakimi+M%22">Klaiber-Hakimi M</searchLink>; Clinic for Hematology, Oncology and Palliative Care, Marien Hospital Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+M%22">Müller M</searchLink>; Clinic for Hematology, Oncology and Immunology, Klinikum Siloah Hannover, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Shumilov+E%22">Shumilov E</searchLink>; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Knauf+W%22">Knauf W</searchLink>; Center for Hematology and Oncology Bethanien, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Michel+CS%22">Michel CS</searchLink>; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Geer+T%22">Geer T</searchLink>; Department of Internal Medicine III, Diakoneo Clinic Schwäbisch-Hall, Schwäbisch-Hall, Germany.<br /><searchLink fieldCode="AU" term="%22Riesenberg+H%22">Riesenberg H</searchLink>; Hematology/Oncology Center, Bielefeld, Germany.<br /><searchLink fieldCode="AU" term="%22Lutz+C%22">Lutz C</searchLink>; Hematology/Oncology Center, Koblenz, Germany.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Benner+A%22">Benner A</searchLink>; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffmann+M%22">Hoffmann M</searchLink>; Medical Clinic A, Clinic Ludwigshafen, Ludwigshafen, Germany.<br /><searchLink fieldCode="AU" term="%22Weisel+KC%22">Weisel KC</searchLink>; Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Salwender+HJ%22">Salwender HJ</searchLink>; Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22German-Speaking+Myeloma+Multicenter+Group+%28GMMG%29+HD7+Investigators%22">German-Speaking Myeloma Multicenter Group (GMMG) HD7 Investigators</searchLink><br /><searchLink fieldCode="CA" term="%22German-speaking+Myeloma+Multicenter+Group+%28GMMG%29+HD7%22">German-speaking Myeloma Multicenter Group (GMMG) HD7</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2025 Apr 10; Vol. 43 (11), pp. 1279-1288. <i>Date of Electronic Publication: </i>2024 Dec 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39652594 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/JCO-24-02266 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1279 Titles: – TitleFull: Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mai EK – PersonEntity: Name: NameFull: Bertsch U – PersonEntity: Name: NameFull: Pozek E – PersonEntity: Name: NameFull: Fenk R – PersonEntity: Name: NameFull: Besemer B – PersonEntity: Name: NameFull: Hanoun C – PersonEntity: Name: NameFull: Schroers R – PersonEntity: Name: NameFull: von Metzler I – PersonEntity: Name: NameFull: Hänel M – PersonEntity: Name: NameFull: Mann C – PersonEntity: Name: NameFull: Leypoldt LB – PersonEntity: Name: NameFull: Heilmeier B – PersonEntity: Name: NameFull: Huhn S – PersonEntity: Name: NameFull: Vogel SK – PersonEntity: Name: NameFull: Hundemer M – PersonEntity: Name: NameFull: Scheid C – PersonEntity: Name: NameFull: Blau IW – PersonEntity: Name: NameFull: Luntz S – PersonEntity: Name: NameFull: Weinhold N – PersonEntity: Name: NameFull: Tichy D – PersonEntity: Name: NameFull: Holderried TAW – PersonEntity: Name: NameFull: Trautmann-Grill K – PersonEntity: Name: NameFull: Gezer D – PersonEntity: Name: NameFull: Klaiber-Hakimi M – PersonEntity: Name: NameFull: Müller M – PersonEntity: Name: NameFull: Shumilov E – PersonEntity: Name: NameFull: Knauf W – PersonEntity: Name: NameFull: Michel CS – PersonEntity: Name: NameFull: Geer T – PersonEntity: Name: NameFull: Riesenberg H – PersonEntity: Name: NameFull: Lutz C – PersonEntity: Name: NameFull: Raab MS – PersonEntity: Name: NameFull: Benner A – PersonEntity: Name: NameFull: Hoffmann M – PersonEntity: Name: NameFull: Weisel KC – PersonEntity: Name: NameFull: Salwender HJ – PersonEntity: Name: NameFull: Goldschmidt H IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 04 Text: 2025 Apr 10 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1527-7755 Numbering: – Type: volume Value: 43 – Type: issue Value: 11 Titles: – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Type: main |
| ResultId | 1 |
